Downregulation of STK4 promotes colon cancer invasion/migration through blocking β-catenin degradation

Related Experiment Video

Updated: Dec 13, 2025

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.3K

Cheng-Han Lin1, Tai-I Hsu1, Pei-Yu Chiou1

  • 1Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Molecular Oncology
|August 3, 2020
PubMed

Insights

Mammalian STE20-like kinase 1 (STK4) is downregulated in colon cancer, promoting metastasis and poor survival. Loss of STK4 leads to beta-catenin accumulation, driving tumor progression and suggesting STK4 as a prognostic marker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Mammalian STE20-like kinase 1 (STK4) is a serine/threonine kinase, homologous to Drosophila Hippo, crucial for cell growth, apoptosis, and organ size regulation.
  • Previous research suggests STK4 involvement in colon cancer lymph node metastasis and its potential as a diagnostic marker, yet its role in promoting colon cancer progression remains understudied.

Purpose of the Study:

  • To investigate the role of STK4 downregulation in colon cancer progression.
  • To elucidate the molecular mechanisms by which STK4 influences colon cancer metastasis and survival.
  • To assess STK4 as a potential prognostic marker for beta-catenin-mediated colon cancer.

Main Methods:

  • Analysis of STK4 expression levels in colon cancer tissues.
  • In vitro studies involving STK4 knockdown to assess sphere formation and metastasis.
  • In vivo tumor development studies following STK4 knockdown.
  • Investigation of STK4 interaction and phosphorylation of beta-catenin.
  • Assessment of the ubiquitin-mediated degradation pathway of beta-catenin.

Main Results:

  • STK4 was found to be significantly downregulated in colon cancer, correlating with distal metastasis and poor patient survival.
  • STK4 knockdown enhanced sphere formation and metastasis in vitro and promoted tumor development in vivo.
  • STK4 directly phosphorylated beta-catenin, leading to its degradation via the ubiquitin-mediated pathway.
  • STK4 knockdown resulted in beta-catenin phosphorylation failure and subsequent accumulation, promoting anchorage-independent growth and metastasis.

Conclusions:

  • STK4 downregulation is a significant factor in colon cancer progression, metastasis, and poor prognosis.
  • The STK4-beta-catenin interaction and subsequent degradation pathway are critical in controlling colon cancer cell growth and metastasis.
  • STK4 serves as a potential prognostic marker for beta-catenin-mediated colon cancer, offering insights into therapeutic strategies.
Keywords:
STK4colon cancersβ-catenin

More Related Videos

The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

113.3K
In vitro Organoid Culture of Primary Mouse Colon Tumors07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

35.7K

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.9K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.0K